Characterization of PGua 4 , a Guanidinium-Rich Peptoid that Delivers IgGs to the Cytosol via Macropinocytosis
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c00783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Andréanne Laniel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke…. Hauptthemen laut MEDLINE: Peptoids. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds de Recherche du Qu?bec - Nature et Technologies, Fonds de recherche du Qu?bec, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
To investigate the structure-cellular penetration relationship of guanidinium-rich transporters (GRTs), we previously designed PGua4, a five-amino acid peptoid containing a conformationally restricted pattern of eight guanidines, which showed high cell-penetrating abilities and low cell toxicity. Herein, we characterized the cellular uptake selectivity, internalization pathway, and intracellular distribution of PGua4, as well as its capacity to deliver cargo. PGua4 exhibits higher penetration efficiency in HeLa cells than in six other cell lines (A549, Caco-2, fibroblast, HEK293, Mia-PaCa2, and MCF7) and is mainly internalized by clathrin-mediated endocytosis and macropinocytosis. Confocal microscopy showed that it remained trapped in endosomes at low concentrations but induced pH-dependent endosomal membrane destabilization at concentrations ≥10 μM, allowing its diffusion into the cytoplasm. Importantly, PGua4 significantly enhanced macropinocytosis and the cellular uptake and cytosolic delivery of large IgGs following noncovalent complexation. Therefore, in addition to its peptoid nature conferring high resistance to proteolysis, PGua4 presents characteristics of a promising tool for IgG delivery and therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Pharmacologie de Sherbrooke, Department of Pharmacology and Physiology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada.
ORCID-Profile: Pierre-Luc Boudreault, Christine Lavoie
Förderung
- Fonds de Recherche du Qu?bec - Nature et Technologies
- Fonds de recherche du Qu?bec
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Laniel, A., Marouseau, É., Nguyen, D. T., Froehlich, U., McCartney, C., Boudreault, P. L., & Lavoie, C. (2023). Characterization of PGua 4 , a Guanidinium-Rich Peptoid that Delivers IgGs to the Cytosol via Macropinocytosis. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c00783
Vancouver
Laniel A, Marouseau É, Nguyen DT, Froehlich U, McCartney C, Boudreault PL, et al. Characterization of PGua 4 , a Guanidinium-Rich Peptoid that Delivers IgGs to the Cytosol via Macropinocytosis. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c00783
BibTeX
@article{Laniel2023,
author = {Laniel, Andréanne and Marouseau, Étienne and Nguyen, Duc Tai and Froehlich, Ulrike and McCartney, Claire and Boudreault, Pierre-Luc and Lavoie, Christine},
title = {Characterization of PGua 4 , a Guanidinium-Rich Peptoid that Delivers IgGs to the Cytosol via Macropinocytosis},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c00783}
}
EUVIMED